The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management?

Citation
Re. Glasgow et al., The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management?, PAT EDUC C, 44(2), 2001, pp. 119-127
Citations number
33
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Public Health & Health Care Science","Envirnomentale Medicine & Public Health
Journal title
PATIENT EDUCATION AND COUNSELING
ISSN journal
0738-3991 → ACNP
Volume
44
Issue
2
Year of publication
2001
Pages
119 - 127
Database
ISI
SICI code
0738-3991(200108)44:2<119:TRFFEI>2.0.ZU;2-6
Abstract
Background: The RE-AIM framework is used as a method of systematically cons idering the strengths and weaknesses of chronic illness management interven tions in order to guide program planning. Method: The RE-AIM dimensions of Reach, Efficacy, Adoption, Implementation, and Maintenance are used to rate one-on-one counseling interventions. group sessions, interactive computer- mediated interventions, telephone calls, mail interventions. and health sys tem policies. Results: The RE-AIM ratings suggest that. although often effi cacious for those participating, traditional face-to-face intervention moda lities will have limited impact if they cannot be delivered consistently to large segments of the target population. Interventions using new informati on technologies may have greater reach, adoption. implementation, and maint enance, and thereby greater public health impact. Policy changes received h igh ratings across a variety of RE-AIM dimensions. Conclusions: Program pla nners should make decisions regarding implementing and funding health servi ces based on multiple dimensions. rather than only considering efficacy in randomized clinical trials. Doing so may improve the resulting public healt h impact. Directions for future chronic illness management research related to RE-AIM, and implications for decision making, are described. (C) 2001 E lsevier Science Ireland Ltd. All rights reserved.